Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Axa Equitable stock
Learn how to easily invest in Axa Equitable stock.
Axa Equitable Holdings Inc is an insurance-diversified business based in the US. Axa Equitable shares (EQH) are listed on the NYSE and all prices are listed in US Dollars. Axa Equitable employs 12,100 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Axa Equitable
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – EQH – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Axa Equitable stock price (NYSE: EQH)Use our graph to track the performance of EQH stocks over time.
Axa Equitable shares at a glance
|Latest market close||$26.32|
|52-week range||$25.22 - $36.67|
|50-day moving average||$28.36|
|200-day moving average||$31.45|
|Wall St. target price||$42.00|
|Dividend yield||$0.55 (3.04%)|
|Earnings per share (TTM)||$3.65|
Buy Axa Equitable shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Axa Equitable stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Axa Equitable price performance over time
|1 week (2022-06-28)||-2.55%|
|1 month (2022-06-06)||-11.35%|
|3 months (2022-04-06)||-16.55%|
|6 months (2022-01-06)||-25.06%|
|1 year (2021-07-06)||-11.08%|
|2 years (2020-07-06)||35.53%|
|3 years (2019-07-05)||20.57%|
|5 years (2017-07-02)||N/A|
Is Axa Equitable stock undervalued or overvalued?
Valuing Axa Equitable stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Axa Equitable's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Axa Equitable's P/E ratio
Axa Equitable's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 7x. In other words, Axa Equitable shares trade at around 7x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Axa Equitable's EBITDA
Axa Equitable's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $5.4 billion.
The EBITDA is a measure of a Axa Equitable's overall financial performance and is widely used to measure a its profitability.
Axa Equitable financials
|Revenue TTM||$16.1 billion|
|Operating margin TTM||30.72%|
|Gross profit TTM||$4.5 billion|
|Return on assets TTM||1.12%|
|Return on equity TTM||18.09%|
|Market capitalisation||$10 billion|
TTM: trailing 12 months
Axa Equitable share dividends
Dividend payout ratio: 11.3% of net profits
Recently Axa Equitable has paid out, on average, around 11.3% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.04% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Axa Equitable shareholders could enjoy a 3.04% return on their shares, in the form of dividend payments. In Axa Equitable's case, that would currently equate to about $0.55 per share.
While Axa Equitable's payout ratio might seem low, this can signify that Axa Equitable is investing more in its future growth.
Axa Equitable's most recent dividend payout was on 5 June 2022. The latest dividend was paid out to all shareholders who bought their shares by 25 May 2022 (the "ex-dividend date").
Axa Equitable share price volatility
Over the last 12 months, Axa Equitable's shares have ranged in value from as little as $25.22 up to $36.6696. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Axa Equitable's is 1.4864. This would suggest that Axa Equitable's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Axa Equitable overview
Equitable Holdings, Inc. , together with its consolidated subsidiaries, operates as a diversified financial services company worldwide. The company operates through four segments: Individual Retirement, Group Retirement, Investment Management and Research, and Protection Solutions. The Individual Retirement segment offers a suite of variable annuity products primarily to affluent and high net worth individuals. The Group Retirement segment provides tax-deferred investment and retirement services or products to plans sponsored by educational entities, municipalities, and not-for-profit entities, as well as small and medium-sized businesses. The Investment Management and Research segment offers diversified investment management, research, and related solutions to various clients through institutional, retail, and private wealth management channels; and distributes its institutional research products and solutions. The Protection Solutions segment provides various variable universal life, indexed universal life, and term life products to help affluent and high net worth individuals, as well as small and medium-sized business owners; and a suite of life, short- and long-term disability, dental, and vision insurance products to small and medium-size businesses.
Axa Equitable in the news
Equitable Announces Investment in SoLa Impact's Black Impact Fund
Equitable Holdings to Participate in the 2022 Morgan Stanley US Financials, Payments and CRE Conference
Equitable Holdings Appoints Craig MacKay to Board of Directors
Frequently asked questionsWhat percentage of Axa Equitable is owned by insiders or institutions?
Currently 0.456% of Axa Equitable shares are held by insiders and 100.906% by institutions. How many people work for Axa Equitable?
Latest data suggests 12,100 work at Axa Equitable. When does the fiscal year end for Axa Equitable?
Axa Equitable's fiscal year ends in December. Where is Axa Equitable based?
Axa Equitable's address is: 1290 Avenue Of The Americas, New York, NY, United States, 10104 What is Axa Equitable's ISIN number?
Axa Equitable's international securities identification number is: US29452E1010 What is Axa Equitable's CUSIP number?
Axa Equitable's Committee on Uniform Securities Identification Procedures number is: 054561105
More guides on Finder
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert